XML 64 R101.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Quarterly Financial Data (Unaudited) (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Quarterly Financial Information Disclosure [Abstract]                      
Revenue $ 112,034 $ 111,291 $ 111,803 $ 103,979 $ 103,603 $ 100,013 $ 101,360 $ 94,496 $ 439,107 $ 399,472 $ 286,776
Gross profit 69,917 69,339 70,240 64,778 63,946 62,737 65,755 58,048 274,274 250,486 172,370
Net income/(loss) 1,576 8,283 8,300 11,685 10,393 16,001 10,444 5,036 52,751 49,814 (1,763)
Net income/(loss) attributable to BioTelemetry, Inc. $ 1,576 $ 8,283 $ 8,300 $ 11,685 $ 10,393 $ 16,001 $ 10,444 $ 5,982 $ 29,844 $ 42,820 $ (15,956)
Basic net income/(loss) per share attributable to BioTelemetry, Inc. $ 0.05 $ 0.24 $ 0.25 $ 0.35 $ 0.31 $ 0.48 $ 0.32 $ 0.18 $ 0.88 $ 1.31 $ (0.53)
Diluted net income/(loss) per share attributable to BioTelemetry, Inc. $ 0.04 $ 0.23 $ 0.23 $ 0.32 $ 0.29 $ 0.45 $ 0.29 $ 0.17 $ 0.82 $ 1.20 $ (0.53)